Literature DB >> 19419738

Opsoclonus-myoclonus syndrome and HIV-infection.

Kirsten M Scott1, Faheema Parker, Jeannine M Heckmann.   

Abstract

Opsoclonus-myoclonus syndrome (OMS) typically presents with chaotic eye movements and myoclonus with some patients exhibiting ataxia and behavioural disturbance. The pathogenesis may be inflammatory with an infectious or paraneoplastic trigger. In this report, we describe four HIV-infected cases with OMS presenting to a tertiary referral centre in Cape Town, South Africa, over a 10-year period. OMS was the initial neurological presentation of HIV-infection in three subjects of whom two had preserved CD4+ cell counts. Immunosuppressive therapy, mainly prednisone, led to a dramatic improvement of symptoms in all cases suggesting an inflammatory aetiology, consistent with the observation that HIV-infection can be associated with both inflammatory and autoimmune conditions. Three previous reports of OMS associated with HIV-infection have been documented including a sero-conversion syndrome and as part of an immune reconstitution syndrome. We suggest that in HIV-associated OMS the pathophysiology may be the consequence of a dysregulated immune system in which a reduced CD4/CD8 ratio, in addition to a critical level of functional CD4+ cells for efficient CD8+ cytotoxicity, results in dysfunction of the brainstem-cerebellar circuitry in susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19419738     DOI: 10.1016/j.jns.2009.04.026

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  9 in total

1.  Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies.

Authors:  Thaís Armangué; Lidia Sabater; Estefanía Torres-Vega; Eugenia Martínez-Hernández; Helena Ariño; Mar Petit-Pedrol; Jesús Planagumà; Luis Bataller; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2016-04       Impact factor: 18.302

Review 2.  HIV-associated opsoclonus-myoclonus-ataxia syndrome: early infection, immune reconstitution syndrome or secondary to other diseases? Case report and literature review.

Authors:  Bruno F Guedes; Márcio A A Vieira Filho; Clarice Listik; Rafael B Carra; Cristiane B Pereira; Emanuelle R da Silva; Hélio R Gomes; José E Vidal
Journal:  J Neurovirol       Date:  2017-12-14       Impact factor: 2.643

3.  West nile virus encephalitis induced opsoclonus-myoclonus syndrome.

Authors:  Chad J Cooper; Sarmad Said
Journal:  Neurol Int       Date:  2014-04-22

4.  Opsoclonus-myoclonus syndrome associated with mumps virus infection.

Authors:  Bong-Hui Kang; Jae-Il Kim
Journal:  J Clin Neurol       Date:  2014-07-03       Impact factor: 3.077

5.  Opsoclonus-myoclonus-ataxia syndrome in an AIDS patient.

Authors:  Thiago Cardoso Vale; Rodrigo Alencar E Silva; Mauro César Quintão E Silva Cunningham; Débora Palma Maia; Sarah Teixeira Camargos; Francisco Cardoso
Journal:  Einstein (Sao Paulo)       Date:  2013-12

6.  Scrub Typhus-Associated Opsoclonus: Clinical Course and Longitudinal Outcomes in an Indian Cohort.

Authors:  Ravikar Ralph; A T Prabhakar; Sowmya Sathyendra; Ronald Carey; John Jude; George M Varghese
Journal:  Ann Indian Acad Neurol       Date:  2019 Apr-Jun       Impact factor: 1.383

7.  Opsoclonus-myoclonus syndrome with severe clinical course and beneficial outcome: A case report.

Authors:  Ewa Koziorowska-Gawron; Magdalena Koszewicz; Joanna Bladowska; Maria Ejma; Slawomir Budrewicz
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

Review 8.  Update on opsoclonus-myoclonus syndrome in adults.

Authors:  Sun-Young Oh; Ji-Soo Kim; Marianne Dieterich
Journal:  J Neurol       Date:  2018-11-27       Impact factor: 4.849

9.  Opsoclonus-myoclonus-ataxia syndrome in an HIV-infected child.

Authors:  Noella Maria Delia Pereira; Ira Shah; Shilpa Kulkarni
Journal:  Oxf Med Case Reports       Date:  2016-10-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.